IMA901
- Generic Name
- IMA901
- Drug Type
- Biotech
Overview
IMA901 is a vaccine consists of tumor-associated peptides (TUMAPs).
Background
IMA901 is a vaccine consists of tumor-associated peptides (TUMAPs).
Indication
Investigated for use/treatment in kidney cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath